• Profile
Close

Prognostic utility of initial lactate in patients with acute drug overdose: A validation cohort

Annals of Emergency Medicine Apr 13, 2018

Cheung R, et al. - This cohort study was planned to formally validate the prognostic utility of the initial lactate concentration for inhospital mortality from acute drug poisoning in a larger, distinct patient population with acute drug overdose. Findings suggested that in Emergency Department (ED) patients with acute drug overdose, initial lactate concentration is a useful biomarker for early clinical decisionmaking.

Methods

  • Researchers conducted an observational, prospective, cohort study during 5 years at 2 urban teaching hospitals.
  • They tested serum lactate levels in consecutive adult ED patients with acute drug overdose as part of clinical care.
  • Inpatient fatality was assessed as the primary outcome.
  • To determine optimal cut points, test characteristics, area under the curve, odds ratios, and 95% confidence intervals (Cis), they plotted receiver operating characteristics.

Results

  • Researchers screened 3,739 patients.
  • Of these, 1,406 were analyzed (56% women; mean age 43.1 years) and 24 died (1.7%).
  • They noted that the difference in mean initial lactate concentration was 5.9 mmol/L (95% CI 3.4 to 8.1 mmol/L) higher in patients who died compared with survivors.
  • For prediction of fatality, the area under the curve was 0.85 (95% CI 0.73 to 0.95).
  • For fatality, the optimal lactate cut point was greater than or equal to 5.0 (odds ratio 34.2; 95% CI 13.7 to 84.2; 94.7% specificity).
  • Drug classes for which lactate showed the greatest utility included salicylates, sympathomimetics, acetaminophen, and opioids (all area under the curve ≥0.97); the lowest utility was shown for diuretics and angiotensin-converting enzyme inhibitors.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay